🔗 Permalink

Inventor profile of:

Robert Bender

City:

Ottawa

Country:

Canada

Published Applications:

Last publication date:

2023-06-29

Top Assignees for applications by Robert Bender

The entities that hold a legal rights for patent applications filed by inventor Bender Robert:

Cortria Corporation 2 Boston, MA United States
Cortria Corporation 2 Needham, MA United States
Pharmena North America Inc. 1 Ottawa, Canada
CheckApp Inc. (a Canadian federal corporation) 1 Ottawa, Canada
Alentic Microscience Inc. 1 Prospect, Nova Scotia, Canada
SGC PHARMA, INC. 1 Ottawa, ON, Canada
SGC Pharma Inc. 1 Wellesley, MA United States
Dermena 1 Ottawa, Canada

Recent patent applications by Bender Robert

Robert Bender from Ottawa, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-06-29

US20230207079A1

Physics

SMARTPHONE-ENABLED SYSTEMS, METHODS, DEVICES, AND COMPUTER PROGRAM PRODUCTS FOR COLLECTING PERFORMANCE DATA AND USING A SELFIE TO GENERATE SELF-VERIFYING DATA SETS

#2 | 2020-06-18

US20200188316A1

Human necessities

TRANSDERMAL FORMULATIONS SUITABLE FOR ADMINISTRATION OF NATURAL PRODUCTS COMPRISING PLANT FLOUR AND AN ADHESIVE

#3 | 2017-02-16

US20170044118A1

Chemistry; metallurgy

SALT COMPOUND

#4 | 2013-11-14

US20130303860A1

Human necessities

SYSTEMS AND METHODS FOR USE IN FALL RISK ASSESSMENT

#5 | 2013-10-24

US20130281888A1

Human necessities

TASK-ASSOCIATED MOTION ANALYSIS

#6 | 2013-09-19

US20130245078A1

Human necessities

Salt compound

#7 | 2012-09-27

US20120245115A1

Human necessities

1-methylnicotinaide derivatives and formulations of treatment of lipoprotein abnormalities

#8 | 2011-04-28

US20110096157A1

Physics

Microscopy imaging

#9 | 2010-09-02

US20100221247A1

Human necessities

AGENTS AND METHODS FOR TREATMENT OF CANCER

#10 | 2010-05-13

US20100120726A1

Human necessities

1-methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities

#11 | 2009-10-08

US20090252704A1

Human necessities

THERAPIES FOR COGNITION AND LEARNING ENHANCEMENT

#12 | 2009-01-15

US20090016956A1

Physics

Labeled Macrophages and Methods of Use Thereof

#13 | 2008-09-18

US20080227831A1

Human necessities

FOOD EXTRACTS FOR TREATMENT OF LIPOPROTEIN ABNORMALITIES AND SKIN DISEASES AND SKIN DISORDERS

#14 | 2007-01-25

US20070021379A1

Human necessities

Methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities

#15 | 2006-12-21

US20060286151A1

Human necessities

Production of foie gras

#16 | 2006-11-16

US20060257466A1

Human necessities

Administration of macrophage targeted formulations of compounds which modulate cholesterol-metabolizing enzymes for treatment of atherosclerosis

#17 | 2005-06-16

US20050131786A1

Physics

Risk shifting for financing intellectual property litigation

InventorID:

445885 ⎘